These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
203 related items for PubMed ID: 9661891
1. Androgen-dependent and -independent human prostate xenograft tumors as models for drug activity evaluation. Chen CT, Gan Y, Au JL, Wientjes MG. Cancer Res; 1998 Jul 01; 58(13):2777-83. PubMed ID: 9661891 [Abstract] [Full Text] [Related]
2. Antiproliferative and cytotoxic effects of geldanamycin, cytochalasin E, suramin and thiacetazone in human prostate xenograft tumor histocultures. Gan Y, Au JL, Lu J, Wientjes MG. Pharm Res; 1998 Nov 01; 15(11):1760-6. PubMed ID: 9834000 [Abstract] [Full Text] [Related]
3. S-allylcysteine, a water-soluble garlic derivative, suppresses the growth of a human androgen-independent prostate cancer xenograft, CWR22R, under in vivo conditions. Chu Q, Lee DT, Tsao SW, Wang X, Wong YC. BJU Int; 2007 Apr 01; 99(4):925-32. PubMed ID: 17155983 [Abstract] [Full Text] [Related]
11. Inhibition of human experimental prostate cancers by a targeted cytotoxic luteinizing hormone-releasing hormone analog AN-207. Stangelberger A, Schally AV, Nagy A, Szepeshazi K, Kanashiro CA, Halmos G. Prostate; 2006 Feb 01; 66(2):200-10. PubMed ID: 16173040 [Abstract] [Full Text] [Related]
12. Acquisition of chemoresistant phenotype by overexpression of the antiapoptotic gene testosterone-repressed prostate message-2 in prostate cancer xenograft models. Miyake H, Nelson C, Rennie PS, Gleave ME. Cancer Res; 2000 May 01; 60(9):2547-54. PubMed ID: 10811138 [Abstract] [Full Text] [Related]
13. Androgen receptor expression in androgen-independent prostate cancer is associated with increased expression of androgen-regulated genes. Gregory CW, Hamil KG, Kim D, Hall SH, Pretlow TG, Mohler JL, French FS. Cancer Res; 1998 Dec 15; 58(24):5718-24. PubMed ID: 9865729 [Abstract] [Full Text] [Related]
14. Response of prostate cancer to anti-Her-2/neu antibody in androgen-dependent and -independent human xenograft models. Agus DB, Scher HI, Higgins B, Fox WD, Heller G, Fazzari M, Cordon-Cardo C, Golde DW. Cancer Res; 1999 Oct 01; 59(19):4761-4. PubMed ID: 10519379 [Abstract] [Full Text] [Related]
17. The suppression of human prostate tumor growth in mice by the intratumoral injection of a slow-release polymeric paste formulation of paclitaxel. Jackson JK, Gleave ME, Yago V, Beraldi E, Hunter WL, Burt HM. Cancer Res; 2000 Aug 01; 60(15):4146-51. PubMed ID: 10945622 [Abstract] [Full Text] [Related]
18. Pharmacodynamics of taxol in human head and neck tumors. Gan Y, Wientjes MG, Schuller DE, Au JL. Cancer Res; 1996 May 01; 56(9):2086-93. PubMed ID: 8616855 [Abstract] [Full Text] [Related]
19. Suberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, suppresses the growth of prostate cancer cells in vitro and in vivo. Butler LM, Agus DB, Scher HI, Higgins B, Rose A, Cordon-Cardo C, Thaler HT, Rifkind RA, Marks PA, Richon VM. Cancer Res; 2000 Sep 15; 60(18):5165-70. PubMed ID: 11016644 [Abstract] [Full Text] [Related]
20. Studies with CWR22 xenografts in nude mice suggest that ZD1839 may have a role in the treatment of both androgen-dependent and androgen-independent human prostate cancer. Sirotnak FM, She Y, Lee F, Chen J, Scher HI. Clin Cancer Res; 2002 Dec 15; 8(12):3870-6. PubMed ID: 12473602 [Abstract] [Full Text] [Related] Page: [Next] [New Search]